Osteoporosis

Balasubramanian A et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4732-1

Lim SJ et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4640-4

van der Velde RY et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4636-0

Li L et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4185-0

Yoshimura N et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4596-4

Antoniou T et al. BMC Musculoskelet Disord 2018; 19: 160. doi: 10.1186/s12891-018-2076-9

Hoff M et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4560-3

Puth MT et al. BMC Musculoskelet Disord 2018; 19: 144. doi: 10.1186/s12891-018-2060-4

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

Quesada-Gomez JM, Bouillon R. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4520-y

The authors provide an overview of transient osteoporosis of the hip, covering the epidemiology, pathophysiology, etiology, diagnosis, treatment, and potential complications of the condition.1

Asadipooya K, Graves L, Greene LW. Osteoporos Int 2017;28:1805–1816. doi:10.1007/s00198-017-3952-0

The authors explore the hypothesis that early life experiences may induce stress reactions and other responses that modify DNA methylation patterns and consequently influence the risk of osteoporosis in later life.

Riancho JA, Brennan-Olsen SL. Clinic Rev Bone Miner Metab 2017;15:59-68. doi:10.1007/s12018-017-9229-5

This research article determined evidence of decline in femur neck bone mineral density (BMD) but not in lumbar spine BDM between 2005–2006 and 2013–2014 in the US population.

Looker AC et al. Osteoporos Int 2017. doi:10.1007/s00198-017-3996-1

The authors could not confirm a positive association between socioeconomic status (SES) and bone mineral density (BMD) but found that those with a poor SES were more vulnerable to lower BMD.

Du Y et al. Osteoporos Int 2017;28:1699–1709. doi:10.1007/s00198-017-3951-1

Studying the prevalence of osteoporosis in USA, Wright et al found that 16% of men and 29.9% of women over 50 years of age have the condition based on National Bone Health Alliance diagnostic criteria.

Wright NC et al. Osteoporos Int 2017;28:1225–1232. doi:10.1007/s00198-016-3865-3

In this chapter, the authors provide an overview of the latest epidemiological data on osteoporosis in the US including rates of osteoporosis and fragility fractures.

Bone Disorders. Springer International Publishing Switzerland, 2017. doi:10.1007/978-3-319-29182-6_16

An expert review of epidemiologic data on the rates of hip and other common fractures among older individuals and future projections on hip and other common fractures.

Bischoff-Ferrari HA. In: Osteoporosis in Older Persons. Edited by Duque G, Kile DP. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-25976-5_9

This chapter explores the epidemiology of osteoporosis and fragility fracture, cell biology and biomechanics, and the latest research on global trends in age- and sex-specific fracture rates.

Moon RJ, Cooper C, Harvey NC. In: The Duration and Safety of Osteoporosis Treatment. Edited by Silverman S, Abrahamsen B. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-23639-1_1